...
机译:Pradigastat和Digoxin或Warfarin之间的药代动力学和药效药物 - 药物相互作用评估
Novartis Institutes for Biomedical Research East Hanover NJ United States;
Novartis Institutes for Biomedical Research Cambridge MA United States;
Novartis Institutes for Biomedical Research Cambridge MA United States;
Novartis Institutes for Biomedical Research Cambridge MA United States;
Novartis Healthcare Pvt. Ltd. Hyderabad India;
Novartis Institutes for Biomedical Research East Hanover NJ United States;
Novartis Institutes for Biomedical Research East Hanover NJ United States;
Novartis Institutes for Biomedical Research East Hanover NJ United States;
Novartis Institutes for Biomedical Research East Hanover NJ United States;
digoxin; interaction; pharmacodynamics; pharmacokinetics; warfarin;
机译:普拉达司他与地高辛或华法林之间的药代动力学和药效学药物相互作用评估
机译:普拉加司他与阿扎那韦或丙磺舒之间药代动力学药物相互作用的评估
机译:普拉达司他与对乙酰氨基酚之间的药代动力学药物相互作用的评估
机译:体内药代动力学/药效学分析埃及抗凝血剂的埃及抗凝血剂冠状动脉释放肽(Rousettus Aegyptiacus)的风险评估(Pteropus Pselaphon)
机译:瑞格列奈代谢和药物-药物相互作用的体外评估:建立基于生理学的药代动力学模型
机译:在健康受试者的1期研究中评估奥贝胆酸与咖啡因咪达唑仑华法林右美沙芬奥美拉唑瑞舒伐他汀和地高辛之间的药代动力学相互作用
机译:Iguratimod与华法林药物 - 药物相互作用的药代动力学和药效学分析